Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-25-000027
Filing Date
2025-07-08
Accepted
2025-07-08 15:20:41
Documents
3
Period of Report
2025-07-08

Document Format Files

Seq Description Document Type Size
1 6-K a6-kcover07082025earningsc.htm 6-K 10622
2 EX-99.1 pressrelease7825earnings.htm EX-99.1 3385
3 pressrelease7825earnings001.jpg GRAPHIC 221810
  Complete submission text file 0001756770-25-000027.txt   320714
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 251110841
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)